Regression of rectal mucosa-associated lymphoid tissue lymphoma but persistence of Helicobacter pylori infection of gastric mucosa after administration of levofloxacin: report of a case

Dis Colon Rectum. 2004 Sep;47(9):1544-6. doi: 10.1007/s10350-004-0575-2. Epub 2004 Aug 19.

Abstract

Purpose: Several articles have reported regression of rectal lymphoma of mucosa-associated lymphoid tissue after anti- Helicobacter pylori therapy. It remains unclear, however, whether lymphoma of rectal mucosa-associated lymphoid tissue is related to Helicobacter pylori infection.

Methods: A 60-year-old woman visited our hospital with a complaint of hematochezia. On colonoscopy a pale, ulcerated protrusion approximately 3.5 cm in diameter was found in the rectum. Pathologic diagnosis of a biopsy specimen was low-grade mucosa-associated lymphoid tissue lymphoma. The patient received a ten-day course of levofloxacin, and the cycle was repeated three times over seven months.

Results: Although persistence of Helicobacter pylori infection was confirmed, the tumor regressed completely.

Conclusion: Our findings in this case suggest that rectal lymphoma of mucosa-associated lymphoid tissue may be related to unknown microorganisms other than Helicobacter pylori. Levofloxacin may be effective for treatment of rectal lymphoma of mucosa-associated lymphoid tissue regardless of Helicobacter pylori infection.

Publication types

  • Case Reports

MeSH terms

  • Anti-Infective Agents / therapeutic use*
  • Female
  • Gastrointestinal Hemorrhage / etiology
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / pathogenicity*
  • Humans
  • Intestinal Mucosa / microbiology
  • Intestinal Mucosa / pathology*
  • Levofloxacin*
  • Lymphoma / drug therapy*
  • Lymphoma / microbiology*
  • Middle Aged
  • Ofloxacin / therapeutic use*
  • Rectal Neoplasms / drug therapy*
  • Rectal Neoplasms / microbiology*
  • Treatment Outcome

Substances

  • Anti-Infective Agents
  • Levofloxacin
  • Ofloxacin